Title: PharmaPoint: Alzheimer's Disease - India Drug Forecast and Market Analysis to 2022
1PharmaPoint Alzheimer's Disease - India Drug
Forecast and Market Analysis to 2022
One-Stop Shop for Business Information
2 Summary
PharmaPoint Alzheimers Disease - India Drug
Forecast and Market Analysis to 2022. There are
no long-term effective therapies for Alzheimers
Disease (AD), so this remains at the top of the
list for unmet needs. While physicians agree that
symptomatic therapies are relatively safe and
effective, these therapies are still lacking
because of they cannot maintain their effects and
lack mechanisms that alter the course of the
disease. The Indian pharmaceutical market
consists primarily of domestically manufactured
generics and is therefore not affected by erosion
of the sales of patented drugs when these
products enter the market. By integrating only
generics into the market, medicines can be easily
distributed to the large population being served
without restricting access by requiring a
co-payment from private insurance companies. This
model of healthcare does not attract
newly-developed agents, but rather those that are
cost-effective.
3- Scope
- Overview of Alzheimers Disease, including
epidemiology, etiology, symptoms, diagnosis,
pathology and treatment guidelines as well as an
overview on the competitive landscape. - Detailed information on the key drugs in India
including product description, safety and
efficacy profiles as well as a SWOT analysis. - Sales forecast for the top drugs in India from
2012-2022. - Analysis of the impact of key events as well
the drivers and restraints affecting India
Alzheimers Disease market.
4- Reasons To Buy
- Understand and capitalize by identifying products
that are most likely to ensure a robust return - Stay ahead of the competition by understanding
the changing competitive landscape for
Alzheimers Disease - Effectively plan your MA and partnership
strategies by identifying drugs with the most
promising sales potential - Make more informed business decisions from
insightful and in-depth analysis of drug
performance - Obtain sales forecast for drugs from 2012-2022 in
India
5 Table of Contents
- Table of Contents
- Introduction
- Disease Overview
- Disease Management
- Competitive Assessment
- Opportunity and Unmet Need
- Pipeline Assessment
- Market Outlook
- Appendix
6Related Reports
- Market Access for Orphan Drugs assessing the
global landscape - Alzheimer's Pipeline Drugs Review, Alzheimer's
Disease Drug Market Forecast - Global Analysis - 2014 Analysis of the Global Drugs of Abuse
Testing Market - 2014 Analysis of the US Drugs of Abuse
Point-of-Care Testing Market - Global Markets and Manufacturing Technologies for
Protein Drugs - Focus on Blood Factors, Vaccines
and Peptide Antibiotics
7Custom Research
- Incase the reports dont match your
requirement then we can do a Custom Research for
you. Our multifarious capabilities, cross-sector
expertise and detailed knowledge of various
markets, put us at a unique position to take up
Custom Research demands of yours. We provide the
specifications of the custom research job to a
dedicated team comprising of researchers,
analysts and industry experts, who have close
experience and understanding of global markets,
competitive landscapes, various business models,
market shares, drivers, restraints and
benchmarks. - http//www.bharatbook.com/customResearch.asp
8 For More Information You Can Visit
- http//www.bharatbook.com/healthcare-market-resear
ch-reports/pharmapoint-alzheimers-disease-india-dr
ug-forecast-and-market-analysis-to-2022.html
Request Sample Pages
Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 For Live
Chat - http//bit.ly/19m3TU4
Follow/Like Us on-